People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

So-called GLP-1 supplements, named to echo the class of glucagon-like peptide-1 agonist drugs that includes Wegovy and Zepbound, are likely to be ineffective for weight loss. “If you can buy it ...

Pfizer recently announced it decided to discontinue clinical trials of its oral GLP-1 medication for weight loss, called danuglipron, after a study participant experienced a liver injury that was ...

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

The active component, semaglutide, works by replicating the hormone GLP-1 in the body ... hunger. Before diving into the details of Ozempic and its 6-Week Plan for weight loss, let's take a ...

Orforglibron, a pill form of GLP-1 weight loss ... treat obesity after injury reported during trial The patients also lost up to 16 pounds, and they hadn’t seen their weight loss plateau by ...

The rise of GLP-1 weight loss ... 53 % expect to stop before completing two additional years. Moreover, among those who have already discontinued treatment, 90 % did so after less than one year.

New research released Thursday morning shows a new, oral GLP-1 ... for weight loss management, and for Type 2 diabetes management in early 2026. Eli Lilly's latest news comes just days after ...

Orforglipron, which could become the first GLP-1 pill ... after one patient in a clinical trial developed signs of liver injury. AstraZeneca is still working on its own weight-loss pills ...

announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for diabetes and weight loss. The trial of the drug ...

GLP-1 drugs have ... obese (BMI ≥25). After six months, women reduced their average body weight from 156 pounds (71 kg) to 137 pounds (62 kg), reflecting a 12% weight loss.